Cell biology of atherosclerosis.
暂无分享,去创建一个
[1] R. Ross,et al. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. , 1993, The American journal of pathology.
[2] J. Thyberg,et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.
[3] P. Libby,et al. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.
[4] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[5] C. Heldin,et al. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner , 1988, The Journal of cell biology.
[6] P. Libby,et al. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[7] R. Ross,et al. Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.
[8] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[9] Julie H. Campbell,et al. Arterial smooth muscle. A multifunctional mesenchymal cell. , 1988, Archives of pathology & laboratory medicine.
[10] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[11] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[12] D. Steinberg,et al. Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.
[13] R. Ross,et al. Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. , 1994, The American journal of pathology.
[14] A. Gown,et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.
[15] A. Gown,et al. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.
[16] P. Libby,et al. Cytokines as modulators of cell proliferation in fibrotic diseases. , 1989, The American review of respiratory disease.
[17] R. Ross,et al. Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.
[18] S. Ylä-Herttuala,et al. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.
[19] D. Loskutoff,et al. The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis , 1990, Annals of the New York Academy of Sciences.
[20] P. Wahl,et al. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? , 1994, The Journal of clinical investigation.
[21] M. Yacoub,et al. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.
[22] R. Ross. George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. , 1981, Arteriosclerosis.